SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-106152
Filing Date
2024-09-12
Accepted
2024-09-12 21:09:53
Documents
2
Period of Report
2024-09-12

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 10843
2 EX-24 ck0002023658-ex24.htm EX-24 14447
  Complete submission text file 0000950170-24-106152.txt   26706
Mailing Address 245 MAIN STREET CAMBRIDGE MA 02142
Business Address 245 MAIN STREET CAMBRIDGE MA 02142 617-785-8308
Bicara Therapeutics Inc. (Issuer) CIK: 0002023658 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address BICARA THERAPEUTICS INC. 116 HUNTINGTON AVENUE, SUITE 703 BOSTON MA 02116
Business Address
Mazumdar Claire (Reporting) CIK: 0002034671 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42271 | Film No.: 241296271